OpenEvidence
NativeAI NativePrivateUpdated November 15, 2026The AI search engine for clinicians — making medical knowledge accessible at the speed of a clinical decision.
- Website
- openevidence.com
- Founded
- 2022
- CEO
- Daniel Nadler
- HQ
- New York, NY, United States
- Stage
- Private
- Revenue
- Not disclosed
- Total Funding
- $1.0B
- Employees
- 201-500
Executive Summary
Updated Nov 12, 2026
What they do
- AI medical search engine giving clinicians cited, evidence-based answers at the point of care
- EHR-embedded, patient-aware clinical intelligence deployed inside Epic at large health systems
- Adjacent clinician tools: ambient scribe, coding support, access/affordability tools and education
Why it matters
- Reports 1.12 million verified US clinician users and tens of millions of monthly consultations
- Content licensing with major journals and societies including ACP and ACR guidance
- Raised $250M at $12B in January 2026, then reportedly $15B by September 2026
Best fit
- Health systems standardizing clinical decision support across physicians, nurses and pharmacists
- Epic-based organizations wanting evidence answers grounded in individual patient records
- Academic medical centers modernizing medical education and point-of-care reference tools
Watch-outs
- Free clinician tier is ad-supported, raising pharma advertising and neutrality questions
- Enterprise EHR offering is recent; contracting, pricing and support maturity still developing
- Rapid product sprawl into scribing and coding overlaps incumbent vendors you may already use
Products & Offerings
OpenEvidence
AI medical search engine and clinical copilot that answers clinician questions with citations to peer-reviewed literature and guidelines, free to verified US healthcare professionals.
Patient Aware Clinical Intelligence
Enterprise EHR integration, including in Epic, that grounds OpenEvidence answers in an individual patient's chart for health-system clinicians.
OpenEvidence Visits
Ambient AI scribe that transcribes patient encounters, drafts structured notes and adds current guidelines and research to the assessment and plan.
Coding Intelligence
Evidence-backed coding and billing support that helps clinicians document and code encounters accurately.
OpenEvidence Access Intelligence
Suite of tools built into the platform that helps clinicians handle patient affordability and access to care at the point of care.
Recent Releases
- OpenEvidence Access IntelligenceProductNewsNov 2026
- LearnProductNewsNov 2026
Latest News
Fierce Healthcare · 3 days ago
Positive01net · 4 days ago
PositiveUnite.AI · 5 days ago
PositiveCASRAI · 6 days ago
NeutralBecker's Physician Leadership · 6 days ago
PositiveUpdated Nov 12, 2026
OpenEvidence has become the default AI clinical reference for many US clinicians. It now has enterprise EHR deployments at Mount Sinai, Sutter Health, Cedars-Sinai, Penn Medicine, Johns Hopkins and NYU Langone, so health systems choosing clinical decision support should put it on the shortlist next to UpToDate and Doximity. Buyers should check how the ad-supported model is governed, review answer validation and audit logging, and get written commercial terms for the Epic-integrated enterprise product. Don't assume free-tier clinician adoption means enterprise readiness.
Signal Provenance
Latest observation date and source for each signal category
| Signal Category | Last Updated | Source |
|---|---|---|
Funding Signals Last funding round, Funding stage | Nov 10, 2026 | Cited web research |
Hiring Velocity Headcount, Headcount growth | Nov 11, 2026 | Research agents (estimate) |
Technical Output Research papers, GitHub activity | Nov 13, 2026 | Hugging Face Hub + news feed + research agents |
News Sentiment News mentions, News sentiment | Nov 15, 2026 | Verified news feed |
Partnership Signals Enterprise partnerships, Distribution partners | Nov 15, 2026 | Research agents (estimate) |
Revenue Indicators ARR estimate, Revenue growth | Nov 15, 2026 | Research agents (estimate) |
Leadership Signals CEO tenure, Founder-led | Nov 15, 2026 | Research agents (estimate) |
Competitive Position Category rank, Market share | Nov 15, 2026 | Research agents (estimate) |
Why this Bluescore?
6 dimensions, each scored 0–10 against all 250 companies. Each adds its weight × score to the Bluescore — see methodology
OpenEvidence's Bluescore of 43.6 rests most on Investment Momentum (6.5, top 24%) and Data & Model Moat (4.5, 61st percentile). Its weakest area is Talent & Research (2.6, 26th percentile).
In plain English
OpenEvidence has a Bluescore of 43.6 out of 100 and ranks #151 of 247. Its strongest areas are Investment Momentum, at 6.5 of 10 and the 76th percentile among the AI250, and Data & Model Moat, at 4.5 of 10 and the 61st percentile. Talent & Research is the weakest area, at 2.6 of 10 and the 26th percentile, while Product Depth, at 4.0 of 10 with a 21% weight, leaves the most points on the table with 12.6 of 21 still unclaimed, so improving it would move the score most.
Written by AI from the scores below and checked against them; updated nightly.
Risks
Updated Nov 12, 2026